

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * neurofilament cytoskeleton organization (GO:0060052) | 9.28315840 |
| 2 | neuronal action potential propagation (GO:0019227) | 6.72110280 |
| 3 | negative regulation of dendrite morphogenesis (GO:0050774) | 6.41448126 |
| 4 | cerebellar granule cell differentiation (GO:0021707) | 5.86895212 |
| 5 | cell migration in hindbrain (GO:0021535) | 5.78046384 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.61903819 |
| 7 | neuromuscular process controlling posture (GO:0050884) | 5.36902768 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.24520418 |
| 9 | detection of temperature stimulus (GO:0016048) | 5.23519636 |
| 10 | axon cargo transport (GO:0008088) | 5.01549861 |
| 11 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.00257034 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.73563451 |
| 13 | proline transport (GO:0015824) | 4.63410520 |
| 14 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.62496476 |
| 15 | sodium ion export (GO:0071436) | 4.61707573 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.60948161 |
| 17 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 4.60785722 |
| 18 | glutamate secretion (GO:0014047) | 4.60431353 |
| 19 | synaptic vesicle exocytosis (GO:0016079) | 4.59047191 |
| 20 | membrane depolarization during action potential (GO:0086010) | 4.57517942 |
| 21 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 4.46951343 |
| 22 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 4.46951343 |
| 23 | cellular potassium ion homeostasis (GO:0030007) | 4.44625857 |
| 24 | positive regulation of synapse maturation (GO:0090129) | 4.42804137 |
| 25 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.40393122 |
| 26 | cell communication by electrical coupling (GO:0010644) | 4.39250282 |
| 27 | negative regulation of dendrite development (GO:2000171) | 4.38893295 |
| 28 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.31706389 |
| 29 | peripheral nervous system neuron development (GO:0048935) | 4.31199526 |
| 30 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.30659854 |
| 31 | synaptic transmission, glutamatergic (GO:0035249) | 4.29027718 |
| 32 | neuronal ion channel clustering (GO:0045161) | 4.23626632 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 4.21638595 |
| 34 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 4.18764424 |
| 35 | mitochondrion transport along microtubule (GO:0047497) | 4.18764424 |
| 36 | negative regulation of microtubule polymerization (GO:0031115) | 4.18296282 |
| 37 | regulation of translational termination (GO:0006449) | 4.16117609 |
| 38 | neurotransmitter secretion (GO:0007269) | 4.13459406 |
| 39 | establishment of mitochondrion localization (GO:0051654) | 4.13251059 |
| 40 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 4.08638668 |
| 41 | regulation of synaptic vesicle transport (GO:1902803) | 4.06703660 |
| 42 | L-amino acid import (GO:0043092) | 4.04683911 |
| 43 | glycine transport (GO:0015816) | 4.02146571 |
| 44 | neuronal action potential (GO:0019228) | 4.01892592 |
| 45 | cerebellar Purkinje cell layer development (GO:0021680) | 4.01577067 |
| 46 | glutamate receptor signaling pathway (GO:0007215) | 4.00373822 |
| 47 | regulation of neurotransmitter secretion (GO:0046928) | 4.00150407 |
| 48 | innervation (GO:0060384) | 4.00120581 |
| 49 | synaptic vesicle endocytosis (GO:0048488) | 3.99267834 |
| 50 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.99222724 |
| 51 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.97641598 |
| 52 | cell communication involved in cardiac conduction (GO:0086065) | 3.95639930 |
| 53 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.93011319 |
| 54 | regulation of synaptic plasticity (GO:0048167) | 3.92582925 |
| 55 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.91777317 |
| 56 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.90261874 |
| 57 | * intermediate filament organization (GO:0045109) | 3.90200752 |
| 58 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.85131035 |
| 59 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.84196173 |
| 60 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.81540304 |
| 61 | cell differentiation in hindbrain (GO:0021533) | 3.80541308 |
| 62 | activation of protein kinase A activity (GO:0034199) | 3.79709933 |
| 63 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.79636970 |
| 64 | long-term memory (GO:0007616) | 3.78294894 |
| 65 | regulation of ARF protein signal transduction (GO:0032012) | 3.73757858 |
| 66 | amino acid import (GO:0043090) | 3.73346388 |
| 67 | organelle transport along microtubule (GO:0072384) | 3.72011114 |
| 68 | positive regulation of potassium ion transport (GO:0043268) | 3.71801948 |
| 69 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.68197015 |
| 70 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.66784623 |
| 71 | regulation of postsynaptic membrane potential (GO:0060078) | 3.66473745 |
| 72 | regulation of neurotransmitter transport (GO:0051588) | 3.63205770 |
| 73 | regulation of sensory perception (GO:0051931) | 3.61136409 |
| 74 | regulation of sensory perception of pain (GO:0051930) | 3.61136409 |
| 75 | locomotory exploration behavior (GO:0035641) | 3.61024029 |
| 76 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.59546470 |
| 77 | layer formation in cerebral cortex (GO:0021819) | 3.59048752 |
| 78 | positive regulation of dendritic spine development (GO:0060999) | 3.58528605 |
| 79 | positive regulation of membrane potential (GO:0045838) | 3.58295536 |
| 80 | vesicle transport along microtubule (GO:0047496) | 3.57561838 |
| 81 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.53965925 |
| 82 | membrane repolarization (GO:0086009) | 3.53220339 |
| 83 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.52815710 |
| 84 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.51892443 |
| 85 | membrane repolarization during action potential (GO:0086011) | 3.50684173 |
| 86 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.48921261 |
| 87 | neuromuscular process controlling balance (GO:0050885) | 3.48888124 |
| 88 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.48416137 |
| 89 | axon ensheathment in central nervous system (GO:0032291) | 3.48036741 |
| 90 | central nervous system myelination (GO:0022010) | 3.48036741 |
| 91 | exploration behavior (GO:0035640) | 3.46825139 |
| 92 | regulation of vesicle fusion (GO:0031338) | 3.45244891 |
| 93 | response to acidic pH (GO:0010447) | 3.43710963 |
| 94 | potassium ion homeostasis (GO:0055075) | 3.43535132 |
| 95 | prepulse inhibition (GO:0060134) | 3.42689833 |
| 96 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.39387365 |
| 97 | neurotransmitter transport (GO:0006836) | 3.38784565 |
| 98 | protein localization to synapse (GO:0035418) | 3.33936428 |
| 99 | membrane depolarization (GO:0051899) | 3.33051079 |
| 100 | regulation of synapse maturation (GO:0090128) | 3.32707419 |
| 101 | regulation of synapse structural plasticity (GO:0051823) | 3.29824551 |
| 102 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.29074413 |
| 103 | plasma membrane repair (GO:0001778) | 3.28570146 |
| 104 | inositol phosphate catabolic process (GO:0071545) | 3.28453186 |
| 105 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.26599328 |
| 106 | anterograde axon cargo transport (GO:0008089) | 3.26159318 |
| 107 | positive regulation of neurotransmitter transport (GO:0051590) | 3.25049780 |
| 108 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.24110135 |
| 109 | transmission of nerve impulse (GO:0019226) | 3.23952463 |
| 110 | neuromuscular process (GO:0050905) | 3.23341614 |
| 111 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.21032197 |
| 112 | potassium ion import (GO:0010107) | 3.20920534 |
| 113 | regulation of membrane repolarization (GO:0060306) | 3.19418169 |
| 114 | regulation of synaptic transmission (GO:0050804) | 3.19033173 |
| 115 | behavioral response to cocaine (GO:0048148) | 3.18946310 |
| 116 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.18129168 |
| 117 | acidic amino acid transport (GO:0015800) | 3.18059668 |
| 118 | positive regulation of axon extension (GO:0045773) | 3.17170165 |
| 119 | microtubule-based transport (GO:0010970) | 3.16357383 |
| 120 | long-term synaptic potentiation (GO:0060291) | 3.14698334 |
| 121 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.14168088 |
| 122 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.13588233 |
| 123 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.12011614 |
| 124 | negative regulation of inclusion body assembly (GO:0090084) | 3.10128021 |
| 125 | postsynaptic membrane organization (GO:0001941) | 3.09888330 |
| 126 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.09201187 |
| 127 | neuron cell-cell adhesion (GO:0007158) | 3.08908791 |
| 128 | synaptic transmission (GO:0007268) | 3.08508533 |
| 129 | neuromuscular synaptic transmission (GO:0007274) | 3.08032206 |
| 130 | cytoskeleton-dependent intracellular transport (GO:0030705) | 3.07456374 |
| 131 | establishment of synaptic vesicle localization (GO:0097480) | 3.06867055 |
| 132 | synaptic vesicle transport (GO:0048489) | 3.06867055 |
| 133 | regulation of neurotransmitter levels (GO:0001505) | 3.05931093 |
| 134 | * intermediate filament cytoskeleton organization (GO:0045104) | 3.05762784 |
| 135 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.04420581 |
| 136 | cellular sodium ion homeostasis (GO:0006883) | 3.04382039 |
| 137 | positive regulation of sodium ion transport (GO:0010765) | 3.03354941 |
| 138 | vocalization behavior (GO:0071625) | 3.02336748 |
| 139 | * intermediate filament-based process (GO:0045103) | 3.01910520 |
| 140 | sodium ion transmembrane transport (GO:0035725) | 3.00550727 |
| 141 | short-term memory (GO:0007614) | 3.00459188 |
| 142 | positive regulation of axonogenesis (GO:0050772) | 3.00135627 |
| 143 | adult walking behavior (GO:0007628) | 2.99649610 |
| 144 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.99350329 |
| 145 | mating behavior (GO:0007617) | 2.99000658 |
| 146 | gamma-aminobutyric acid transport (GO:0015812) | 2.98577227 |
| 147 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.97574858 |
| 148 | calcium ion-dependent exocytosis (GO:0017156) | 2.96644923 |
| 149 | C4-dicarboxylate transport (GO:0015740) | 2.96466264 |
| 150 | regulation of exocytosis (GO:0017157) | 2.96381125 |
| 151 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.96330620 |
| 152 | enteric nervous system development (GO:0048484) | 2.94349155 |
| 153 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.94032139 |
| 154 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.93180894 |
| 155 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.93180894 |
| 156 | suckling behavior (GO:0001967) | 2.90540916 |
| 157 | cellular potassium ion transport (GO:0071804) | 2.89909636 |
| 158 | potassium ion transmembrane transport (GO:0071805) | 2.89909636 |
| 159 | action potential (GO:0001508) | 2.89829019 |
| 160 | axon regeneration (GO:0031103) | 2.87496829 |
| 161 | negative regulation of cation channel activity (GO:2001258) | 2.87485254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.62283422 |
| 2 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.18377223 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.17200900 |
| 4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.11581260 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.99901329 |
| 6 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.94219440 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.92149600 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.90815994 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.90815994 |
| 10 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.71873767 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.64671360 |
| 12 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.57086378 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.56472241 |
| 14 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.46794190 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.39113329 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.34308964 |
| 17 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.28749462 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.20438613 |
| 19 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.20029851 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15449298 |
| 21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.05049038 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.04848241 |
| 23 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.04000826 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.01651617 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.94799125 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.90832506 |
| 27 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.90796658 |
| 28 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74309238 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.71824081 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.71696619 |
| 31 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.69920171 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.65693510 |
| 33 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.65365043 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.65229494 |
| 35 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.64727099 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.64677094 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.62431474 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.60301575 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.56694890 |
| 40 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.53133829 |
| 41 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.44729586 |
| 42 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.41222381 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40832326 |
| 44 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.37567774 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37423484 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36299597 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.33491732 |
| 48 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.31523482 |
| 49 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31150542 |
| 50 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30796705 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29986331 |
| 52 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28593025 |
| 53 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.25828975 |
| 54 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.24708234 |
| 55 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24689869 |
| 56 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23878441 |
| 57 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19501999 |
| 58 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.18775568 |
| 59 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17968561 |
| 60 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.17877253 |
| 61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.17652054 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.17581784 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16603727 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16445121 |
| 65 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.15863025 |
| 66 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.15728160 |
| 67 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15465030 |
| 68 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14703296 |
| 69 | P300_19829295_ChIP-Seq_ESCs_Human | 1.14622840 |
| 70 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14502886 |
| 71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13221736 |
| 72 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.12217572 |
| 73 | * AR_19668381_ChIP-Seq_PC3_Human | 1.12095823 |
| 74 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.12018833 |
| 75 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10663834 |
| 76 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.10539581 |
| 77 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09821127 |
| 78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09713264 |
| 79 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07763673 |
| 80 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06417283 |
| 81 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.05367227 |
| 82 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.03959898 |
| 83 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03150931 |
| 84 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.02655785 |
| 85 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.01944525 |
| 86 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01126885 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00588724 |
| 88 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00449952 |
| 89 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98102908 |
| 90 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.97224818 |
| 91 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.97182663 |
| 92 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96580886 |
| 93 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.96516721 |
| 94 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96187614 |
| 95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95915870 |
| 96 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.94999140 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94829740 |
| 98 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.93419437 |
| 99 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93070735 |
| 100 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.91015952 |
| 101 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.90924319 |
| 102 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90769819 |
| 103 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.90616217 |
| 104 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89928011 |
| 105 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89906417 |
| 106 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89231735 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88987704 |
| 108 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.88409201 |
| 109 | TCF4_23295773_ChIP-Seq_U87_Human | 0.88218847 |
| 110 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87881646 |
| 111 | P68_20966046_ChIP-Seq_HELA_Human | 0.87774831 |
| 112 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87427695 |
| 113 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87331225 |
| 114 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87128121 |
| 115 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85383931 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85043653 |
| 117 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.84680889 |
| 118 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.83742373 |
| 119 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.82846916 |
| 120 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.81411256 |
| 121 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81411256 |
| 122 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81403447 |
| 123 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.81096499 |
| 124 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.80557603 |
| 125 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79864380 |
| 126 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.79542740 |
| 127 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.79261501 |
| 128 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78360427 |
| 129 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.77550769 |
| 130 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77174720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002735_abnormal_chemical_nociception | 5.67523494 |
| 2 | MP0004270_analgesia | 4.54608636 |
| 3 | MP0001968_abnormal_touch/_nociception | 4.50000227 |
| 4 | MP0002736_abnormal_nociception_after | 4.25441100 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.99770733 |
| 6 | MP0004858_abnormal_nervous_system | 3.85305266 |
| 7 | MP0003880_abnormal_central_pattern | 3.75626589 |
| 8 | MP0002734_abnormal_mechanical_nocicepti | 3.46228686 |
| 9 | MP0006276_abnormal_autonomic_nervous | 3.46189148 |
| 10 | MP0002733_abnormal_thermal_nociception | 3.38532757 |
| 11 | MP0009046_muscle_twitch | 3.34281118 |
| 12 | MP0003635_abnormal_synaptic_transmissio | 3.01520164 |
| 13 | MP0004147_increased_porphyrin_level | 2.97418769 |
| 14 | MP0001970_abnormal_pain_threshold | 2.87094976 |
| 15 | * MP0002272_abnormal_nervous_system | 2.71762064 |
| 16 | MP0001348_abnormal_lacrimal_gland | 2.54219834 |
| 17 | MP0003329_amyloid_beta_deposits | 2.46717699 |
| 18 | MP0002067_abnormal_sensory_capabilities | 2.46552860 |
| 19 | MP0002064_seizures | 2.41370227 |
| 20 | MP0001986_abnormal_taste_sensitivity | 2.40701142 |
| 21 | MP0009745_abnormal_behavioral_response | 2.27135522 |
| 22 | MP0002184_abnormal_innervation | 2.18290158 |
| 23 | MP0002063_abnormal_learning/memory/cond | 2.12771990 |
| 24 | MP0008569_lethality_at_weaning | 2.08044731 |
| 25 | MP0001486_abnormal_startle_reflex | 2.00190288 |
| 26 | * MP0000955_abnormal_spinal_cord | 1.95020752 |
| 27 | MP0003787_abnormal_imprinting | 1.92457282 |
| 28 | MP0004142_abnormal_muscle_tone | 1.89085411 |
| 29 | MP0005423_abnormal_somatic_nervous | 1.88860575 |
| 30 | * MP0004811_abnormal_neuron_physiology | 1.85917530 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 1.76417606 |
| 32 | MP0010386_abnormal_urinary_bladder | 1.60899845 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.56971323 |
| 34 | MP0002751_abnormal_autonomic_nervous | 1.54050384 |
| 35 | MP0003633_abnormal_nervous_system | 1.49508593 |
| 36 | * MP0002229_neurodegeneration | 1.47025097 |
| 37 | MP0001501_abnormal_sleep_pattern | 1.44494514 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.44371712 |
| 39 | * MP0002882_abnormal_neuron_morphology | 1.39980977 |
| 40 | MP0004924_abnormal_behavior | 1.37398891 |
| 41 | MP0005386_behavior/neurological_phenoty | 1.37398891 |
| 42 | MP0003123_paternal_imprinting | 1.32792106 |
| 43 | * MP0002066_abnormal_motor_capabilities/c | 1.32548630 |
| 44 | MP0000604_amyloidosis | 1.31552800 |
| 45 | MP0000751_myopathy | 1.30864210 |
| 46 | MP0000778_abnormal_nervous_system | 1.29464379 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.28416610 |
| 48 | MP0005083_abnormal_biliary_tract | 1.24670801 |
| 49 | MP0001299_abnormal_eye_distance/ | 1.23706263 |
| 50 | MP0000920_abnormal_myelination | 1.22994347 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.22289089 |
| 52 | MP0003634_abnormal_glial_cell | 1.22060640 |
| 53 | MP0003631_nervous_system_phenotype | 1.21245602 |
| 54 | MP0005623_abnormal_meninges_morphology | 1.21090299 |
| 55 | MP0003879_abnormal_hair_cell | 1.13721311 |
| 56 | MP0002557_abnormal_social/conspecific_i | 1.13179688 |
| 57 | MP0001188_hyperpigmentation | 1.09290581 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.08693467 |
| 59 | MP0002638_abnormal_pupillary_reflex | 1.07151174 |
| 60 | MP0001177_atelectasis | 1.06323607 |
| 61 | MP0009780_abnormal_chondrocyte_physiolo | 1.01551780 |
| 62 | MP0003011_delayed_dark_adaptation | 1.01550372 |
| 63 | MP0000747_muscle_weakness | 1.01031848 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 0.99306998 |
| 65 | * MP0002752_abnormal_somatic_nervous | 0.97805341 |
| 66 | MP0001963_abnormal_hearing_physiology | 0.91443814 |
| 67 | MP0003698_abnormal_male_reproductive | 0.91203175 |
| 68 | MP0004885_abnormal_endolymph | 0.89692572 |
| 69 | MP0001485_abnormal_pinna_reflex | 0.89132850 |
| 70 | MP0001984_abnormal_olfaction | 0.87958419 |
| 71 | MP0003632_abnormal_nervous_system | 0.80257834 |
| 72 | MP0000749_muscle_degeneration | 0.79378176 |
| 73 | MP0001849_ear_inflammation | 0.75497384 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 0.74903317 |
| 75 | MP0001270_distended_abdomen | 0.73322505 |
| 76 | MP0002161_abnormal_fertility/fecundity | 0.72630927 |
| 77 | MP0000534_abnormal_ureter_morphology | 0.72459580 |
| 78 | MP0004085_abnormal_heartbeat | 0.71931627 |
| 79 | MP0008874_decreased_physiological_sensi | 0.71704429 |
| 80 | MP0005409_darkened_coat_color | 0.71096325 |
| 81 | MP0008872_abnormal_physiological_respon | 0.66978531 |
| 82 | MP0003283_abnormal_digestive_organ | 0.66632296 |
| 83 | MP0002152_abnormal_brain_morphology | 0.66490088 |
| 84 | MP0003122_maternal_imprinting | 0.66064761 |
| 85 | MP0005535_abnormal_body_temperature | 0.65436469 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.63731279 |
| 87 | MP0002837_dystrophic_cardiac_calcinosis | 0.63043765 |
| 88 | MP0003646_muscle_fatigue | 0.62876760 |
| 89 | MP0001765_abnormal_ion_homeostasis | 0.62210890 |
| 90 | MP0005670_abnormal_white_adipose | 0.61985541 |
| 91 | MP0004742_abnormal_vestibular_system | 0.61963238 |
| 92 | MP0008260_abnormal_autophagy | 0.61140889 |
| 93 | MP0004036_abnormal_muscle_relaxation | 0.60869680 |
| 94 | MP0004510_myositis | 0.60599536 |
| 95 | MP0000372_irregular_coat_pigmentation | 0.58061367 |
| 96 | MP0001905_abnormal_dopamine_level | 0.57618706 |
| 97 | MP0001664_abnormal_digestion | 0.57332901 |
| 98 | MP0000566_synostosis | 0.57314561 |
| 99 | MP0003045_fibrosis | 0.56867914 |
| 100 | MP0002089_abnormal_postnatal_growth/wei | 0.56537682 |
| 101 | MP0003137_abnormal_impulse_conducting | 0.56507055 |
| 102 | MP0002090_abnormal_vision | 0.55786835 |
| 103 | MP0009379_abnormal_foot_pigmentation | 0.55408357 |
| 104 | MP0005410_abnormal_fertilization | 0.55064312 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.54713314 |
| 106 | MP0003690_abnormal_glial_cell | 0.54538345 |
| 107 | MP0001929_abnormal_gametogenesis | 0.54386782 |
| 108 | MP0000569_abnormal_digit_pigmentation | 0.54158912 |
| 109 | MP0001529_abnormal_vocalization | 0.53647236 |
| 110 | MP0003121_genomic_imprinting | 0.52912646 |
| 111 | MP0005645_abnormal_hypothalamus_physiol | 0.52747188 |
| 112 | MP0010768_mortality/aging | 0.52530661 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.52518757 |
| 114 | MP0006035_abnormal_mitochondrial_morpho | 0.52423393 |
| 115 | MP0005646_abnormal_pituitary_gland | 0.51961687 |
| 116 | MP0002822_catalepsy | 0.51645753 |
| 117 | MP0002082_postnatal_lethality | 0.51541689 |
| 118 | MP0010770_preweaning_lethality | 0.51541689 |
| 119 | MP0003956_abnormal_body_size | 0.51166627 |
| 120 | * MP0003861_abnormal_nervous_system | 0.51142335 |
| 121 | MP0001943_abnormal_respiration | 0.51014994 |
| 122 | MP0002069_abnormal_eating/drinking_beha | 0.50813675 |
| 123 | MP0002234_abnormal_pharynx_morphology | 0.50765669 |
| 124 | MP0002873_normal_phenotype | 0.50345390 |
| 125 | MP0005394_taste/olfaction_phenotype | 0.49468640 |
| 126 | MP0001502_abnormal_circadian_rhythm | 0.48333210 |
| 127 | MP0010769_abnormal_survival | 0.47813733 |
| 128 | MP0004883_abnormal_blood_vessel | 0.47267587 |
| 129 | MP0004484_altered_response_of | 0.47034276 |
| 130 | MP0002269_muscular_atrophy | 0.44956425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ulnar claw (HP:0001178) | 9.05544083 |
| 2 | Myokymia (HP:0002411) | 7.77582892 |
| 3 | Action tremor (HP:0002345) | 6.15406433 |
| 4 | Segmental peripheral demyelination/remyelination (HP:0003481) | 5.73580922 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 5.12680962 |
| 6 | Focal motor seizures (HP:0011153) | 5.06469564 |
| 7 | Insidious onset (HP:0003587) | 4.81720597 |
| 8 | Termporal pattern (HP:0011008) | 4.81720597 |
| 9 | Atonic seizures (HP:0010819) | 4.78220068 |
| 10 | Pheochromocytoma (HP:0002666) | 4.68720005 |
| 11 | Febrile seizures (HP:0002373) | 4.63453823 |
| 12 | Limb dystonia (HP:0002451) | 4.28088260 |
| 13 | Hammertoe (HP:0001765) | 4.27374053 |
| 14 | Neuroendocrine neoplasm (HP:0100634) | 4.21947188 |
| 15 | Foot dorsiflexor weakness (HP:0009027) | 4.05970836 |
| 16 | Focal seizures (HP:0007359) | 4.02569935 |
| 17 | Steppage gait (HP:0003376) | 3.98315848 |
| 18 | Ventricular fibrillation (HP:0001663) | 3.88567601 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 3.85238956 |
| 20 | Abnormality of binocular vision (HP:0011514) | 3.83413550 |
| 21 | Diplopia (HP:0000651) | 3.83413550 |
| 22 | Ankle clonus (HP:0011448) | 3.80636089 |
| 23 | Abnormality of the foot musculature (HP:0001436) | 3.67284867 |
| 24 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 3.64881029 |
| 25 | Dysmetric saccades (HP:0000641) | 3.64399864 |
| 26 | Onion bulb formation (HP:0003383) | 3.56701871 |
| 27 | Visual hallucinations (HP:0002367) | 3.53016945 |
| 28 | Urinary urgency (HP:0000012) | 3.45472482 |
| 29 | Absence seizures (HP:0002121) | 3.39318038 |
| 30 | Decreased motor nerve conduction velocity (HP:0003431) | 3.34372536 |
| 31 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 3.31385441 |
| 32 | Hypercortisolism (HP:0001578) | 3.27523041 |
| 33 | Neurofibrillary tangles (HP:0002185) | 3.26825422 |
| 34 | Cerebral hypomyelination (HP:0006808) | 3.24749951 |
| 35 | Spastic gait (HP:0002064) | 3.21583628 |
| 36 | Status epilepticus (HP:0002133) | 3.20143818 |
| 37 | Focal dystonia (HP:0004373) | 3.18253113 |
| 38 | Truncal ataxia (HP:0002078) | 3.17346417 |
| 39 | Distal sensory impairment (HP:0002936) | 3.16261830 |
| 40 | Generalized tonic-clonic seizures (HP:0002069) | 3.02639101 |
| 41 | Abnormality of pain sensation (HP:0010832) | 3.01844766 |
| 42 | Impaired pain sensation (HP:0007328) | 3.01844766 |
| 43 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.95867574 |
| 44 | Scanning speech (HP:0002168) | 2.94129243 |
| 45 | Dialeptic seizures (HP:0011146) | 2.93315891 |
| 46 | Peripheral hypomyelination (HP:0007182) | 2.91613620 |
| 47 | Tetraplegia (HP:0002445) | 2.87531693 |
| 48 | Mutism (HP:0002300) | 2.83139176 |
| 49 | Failure to thrive in infancy (HP:0001531) | 2.81526736 |
| 50 | Obstructive sleep apnea (HP:0002870) | 2.81505316 |
| 51 | Cerebral inclusion bodies (HP:0100314) | 2.80380772 |
| 52 | Slow saccadic eye movements (HP:0000514) | 2.80084807 |
| 53 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.76055641 |
| 54 | Epileptic encephalopathy (HP:0200134) | 2.74091795 |
| 55 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.72270512 |
| 56 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.72055517 |
| 57 | Abnormality of the vocal cords (HP:0008777) | 2.69972741 |
| 58 | Abnormality of the corticospinal tract (HP:0002492) | 2.65840412 |
| 59 | Craniofacial dystonia (HP:0012179) | 2.61174431 |
| 60 | Rigidity (HP:0002063) | 2.59493586 |
| 61 | Muscle stiffness (HP:0003552) | 2.52948854 |
| 62 | Epileptiform EEG discharges (HP:0011182) | 2.51597100 |
| 63 | Papilledema (HP:0001085) | 2.50817716 |
| 64 | Neoplasm of the heart (HP:0100544) | 2.50437800 |
| 65 | Depression (HP:0000716) | 2.50108858 |
| 66 | Neuronal loss in central nervous system (HP:0002529) | 2.46153934 |
| 67 | Abnormality of the lower motor neuron (HP:0002366) | 2.42908417 |
| 68 | Akinesia (HP:0002304) | 2.38122021 |
| 69 | Lower limb muscle weakness (HP:0007340) | 2.35263265 |
| 70 | Broad-based gait (HP:0002136) | 2.34483009 |
| 71 | Dysautonomia (HP:0002459) | 2.32235510 |
| 72 | Paraplegia (HP:0010550) | 2.31840659 |
| 73 | Dysmetria (HP:0001310) | 2.30904516 |
| 74 | Insomnia (HP:0100785) | 2.28061632 |
| 75 | Amblyopia (HP:0000646) | 2.27782311 |
| 76 | Gaze-evoked nystagmus (HP:0000640) | 2.26001066 |
| 77 | Myotonia (HP:0002486) | 2.24254074 |
| 78 | Poor eye contact (HP:0000817) | 2.24192107 |
| 79 | Postural tremor (HP:0002174) | 2.24010320 |
| 80 | Hemiparesis (HP:0001269) | 2.23542501 |
| 81 | Abnormal eating behavior (HP:0100738) | 2.23181443 |
| 82 | Annular pancreas (HP:0001734) | 2.21477915 |
| 83 | Spastic paraplegia (HP:0001258) | 2.19788463 |
| 84 | Sleep apnea (HP:0010535) | 2.18058523 |
| 85 | Abnormality of the musculature of the hand (HP:0001421) | 2.18003950 |
| 86 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17259381 |
| 87 | Postural instability (HP:0002172) | 2.16701299 |
| 88 | Hyporeflexia of lower limbs (HP:0002600) | 2.16686576 |
| 89 | Gait ataxia (HP:0002066) | 2.15846072 |
| 90 | Anxiety (HP:0000739) | 2.13336995 |
| 91 | Horizontal nystagmus (HP:0000666) | 2.13329512 |
| 92 | CNS hypomyelination (HP:0003429) | 2.12588620 |
| 93 | Hypoplasia of the brainstem (HP:0002365) | 2.10738833 |
| 94 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.10738833 |
| 95 | Distal arthrogryposis (HP:0005684) | 2.09277738 |
| 96 | Resting tremor (HP:0002322) | 2.08534547 |
| 97 | Hypoventilation (HP:0002791) | 2.07294058 |
| 98 | Limb ataxia (HP:0002070) | 2.06057667 |
| 99 | Fetal akinesia sequence (HP:0001989) | 2.05357031 |
| 100 | Bundle branch block (HP:0011710) | 2.03314783 |
| 101 | Progressive inability to walk (HP:0002505) | 2.02424073 |
| 102 | Choreoathetosis (HP:0001266) | 2.01396582 |
| 103 | Clonus (HP:0002169) | 2.01070789 |
| 104 | Hypothermia (HP:0002045) | 2.00702626 |
| 105 | Peripheral demyelination (HP:0011096) | 2.00531799 |
| 106 | Spastic tetraparesis (HP:0001285) | 2.00157018 |
| 107 | Delusions (HP:0000746) | 1.99520317 |
| 108 | Hemiplegia (HP:0002301) | 1.99022240 |
| 109 | Stereotypic behavior (HP:0000733) | 1.98708916 |
| 110 | Menstrual irregularities (HP:0000858) | 1.97249803 |
| 111 | Rapidly progressive (HP:0003678) | 1.97055404 |
| 112 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.96503272 |
| 113 | Bradykinesia (HP:0002067) | 1.95967001 |
| 114 | Areflexia of lower limbs (HP:0002522) | 1.95532187 |
| 115 | Cerebral hemorrhage (HP:0001342) | 1.95128849 |
| 116 | Pes cavus (HP:0001761) | 1.94890193 |
| 117 | Bradycardia (HP:0001662) | 1.93699942 |
| 118 | Dysdiadochokinesis (HP:0002075) | 1.93325246 |
| 119 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.92554071 |
| 120 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.92554071 |
| 121 | Incomplete penetrance (HP:0003829) | 1.91989415 |
| 122 | Impaired proprioception (HP:0010831) | 1.87369995 |
| 123 | Hypsarrhythmia (HP:0002521) | 1.85771463 |
| 124 | Apathy (HP:0000741) | 1.85451623 |
| 125 | Aplasia involving bones of the extremities (HP:0009825) | 1.83541351 |
| 126 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.83541351 |
| 127 | Aplasia of the phalanges of the hand (HP:0009802) | 1.83541351 |
| 128 | Diminished motivation (HP:0000745) | 1.83059591 |
| 129 | Abnormality of saccadic eye movements (HP:0000570) | 1.82199557 |
| 130 | Amelogenesis imperfecta (HP:0000705) | 1.81014940 |
| 131 | Slow progression (HP:0003677) | 1.80303645 |
| 132 | Abnormal social behavior (HP:0012433) | 1.79538112 |
| 133 | Impaired social interactions (HP:0000735) | 1.79538112 |
| 134 | Torticollis (HP:0000473) | 1.78139225 |
| 135 | Impaired vibratory sensation (HP:0002495) | 1.77278427 |
| 136 | Impaired smooth pursuit (HP:0007772) | 1.76916461 |
| 137 | Increased circulating renin level (HP:0000848) | 1.75799768 |
| 138 | Dysarthria (HP:0001260) | 1.75338947 |
| 139 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.75279531 |
| 140 | Lower limb asymmetry (HP:0100559) | 1.75229268 |
| 141 | Thyroid carcinoma (HP:0002890) | 1.73037405 |
| 142 | Intention tremor (HP:0002080) | 1.72777497 |
| 143 | Prolonged QT interval (HP:0001657) | 1.72128118 |
| 144 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.72010473 |
| 145 | Abnormal EKG (HP:0003115) | 1.66828258 |
| 146 | Heart block (HP:0012722) | 1.66609758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.77004223 |
| 2 | MINK1 | 4.60245552 |
| 3 | LMTK2 | 4.49094965 |
| 4 | EPHA4 | 4.33223387 |
| 5 | MAP3K9 | 3.51520896 |
| 6 | MAP3K12 | 2.98370039 |
| 7 | WNK1 | 2.90232781 |
| 8 | MAP3K4 | 2.81614529 |
| 9 | KSR2 | 2.74504163 |
| 10 | LATS2 | 2.62462975 |
| 11 | NTRK1 | 2.62239719 |
| 12 | MAP2K4 | 2.40902284 |
| 13 | LIMK1 | 2.31438997 |
| 14 | MAP2K7 | 2.25244843 |
| 15 | TESK1 | 2.12094016 |
| 16 | SCYL2 | 2.09575060 |
| 17 | PHKG1 | 2.04647772 |
| 18 | PHKG2 | 2.04647772 |
| 19 | STK39 | 1.90753867 |
| 20 | PAK6 | 1.88544032 |
| 21 | MAP3K2 | 1.88130899 |
| 22 | WNK4 | 1.80136615 |
| 23 | RET | 1.76665972 |
| 24 | CAMKK1 | 1.56686038 |
| 25 | MAPKAPK3 | 1.54257353 |
| 26 | CAMK1 | 1.50684692 |
| 27 | STK38 | 1.43240652 |
| 28 | CASK | 1.39685001 |
| 29 | NEK1 | 1.36919434 |
| 30 | RIPK1 | 1.34367118 |
| 31 | BRAF | 1.33607502 |
| 32 | AKT3 | 1.32264484 |
| 33 | MAP3K13 | 1.25138620 |
| 34 | MYLK | 1.24363687 |
| 35 | MAPK13 | 1.21739913 |
| 36 | TNK2 | 1.21107578 |
| 37 | MARK1 | 1.20780624 |
| 38 | CAMK2B | 1.17431103 |
| 39 | NEK6 | 1.17328768 |
| 40 | MAP3K11 | 1.16936486 |
| 41 | GRK5 | 1.14316623 |
| 42 | CDK5 | 1.10331222 |
| 43 | CAMK1G | 1.07758275 |
| 44 | SGK223 | 1.05662966 |
| 45 | SGK494 | 1.05662966 |
| 46 | CAMKK2 | 1.04298802 |
| 47 | PINK1 | 1.03336893 |
| 48 | PRKCG | 1.03006764 |
| 49 | CDK19 | 1.02848918 |
| 50 | MARK2 | 1.02089558 |
| 51 | PRPF4B | 0.98464461 |
| 52 | TYRO3 | 0.98324431 |
| 53 | MAP3K1 | 0.95434060 |
| 54 | ARAF | 0.95009524 |
| 55 | MAPKAPK5 | 0.94424329 |
| 56 | MAP2K1 | 0.93018655 |
| 57 | UHMK1 | 0.91127359 |
| 58 | FER | 0.89297044 |
| 59 | PNCK | 0.85501340 |
| 60 | SGK1 | 0.84741249 |
| 61 | RIPK4 | 0.83772697 |
| 62 | RPS6KA2 | 0.83066695 |
| 63 | MATK | 0.83056935 |
| 64 | CAMK1D | 0.81181485 |
| 65 | PRKD3 | 0.79345961 |
| 66 | PRKCH | 0.78935566 |
| 67 | SGK2 | 0.78127713 |
| 68 | PDPK1 | 0.75989959 |
| 69 | PRKG2 | 0.74309456 |
| 70 | PDK1 | 0.73721661 |
| 71 | DMPK | 0.73386943 |
| 72 | DYRK1A | 0.69051357 |
| 73 | SIK2 | 0.67539298 |
| 74 | SGK3 | 0.67174469 |
| 75 | NEK9 | 0.67101308 |
| 76 | DAPK3 | 0.66752624 |
| 77 | ROCK2 | 0.66107777 |
| 78 | GRK7 | 0.66092149 |
| 79 | CDC42BPA | 0.65032248 |
| 80 | ALK | 0.63770399 |
| 81 | PAK2 | 0.63282500 |
| 82 | TAOK1 | 0.61063769 |
| 83 | ADRBK1 | 0.60993174 |
| 84 | CSNK1E | 0.59870498 |
| 85 | CAMK2G | 0.59442526 |
| 86 | EEF2K | 0.57637846 |
| 87 | MAPK12 | 0.57094620 |
| 88 | BRSK1 | 0.57025780 |
| 89 | CAMK4 | 0.56665080 |
| 90 | KSR1 | 0.55991400 |
| 91 | CDK14 | 0.55455454 |
| 92 | ROCK1 | 0.54104563 |
| 93 | MAPK10 | 0.52554995 |
| 94 | FES | 0.51528445 |
| 95 | EPHA3 | 0.50346596 |
| 96 | CAMK2A | 0.47252214 |
| 97 | CDK18 | 0.45633301 |
| 98 | PRKG1 | 0.45531574 |
| 99 | CSNK1G2 | 0.42827224 |
| 100 | MUSK | 0.42534813 |
| 101 | MOS | 0.42190328 |
| 102 | CDK15 | 0.41778571 |
| 103 | MAP2K6 | 0.41020407 |
| 104 | FYN | 0.40578311 |
| 105 | PKN1 | 0.40219915 |
| 106 | PAK3 | 0.40211511 |
| 107 | CSNK1G3 | 0.40013961 |
| 108 | PLK2 | 0.39000221 |
| 109 | PRKCA | 0.38902836 |
| 110 | PDK4 | 0.38681111 |
| 111 | PDK3 | 0.38681111 |
| 112 | PRKACB | 0.38619630 |
| 113 | CSNK1A1 | 0.38403319 |
| 114 | TESK2 | 0.37521246 |
| 115 | NTRK2 | 0.37413247 |
| 116 | CDK11A | 0.34808554 |
| 117 | STK11 | 0.34228933 |
| 118 | PRKCZ | 0.33951989 |
| 119 | SIK3 | 0.33081933 |
| 120 | RPS6KA3 | 0.33039107 |
| 121 | PRKACA | 0.30810423 |
| 122 | PRKACG | 0.27594520 |
| 123 | DAPK2 | 0.27230901 |
| 124 | AURKA | 0.27225118 |
| 125 | OXSR1 | 0.27222247 |
| 126 | MAPK8 | 0.26615224 |
| 127 | PRKCE | 0.26411878 |
| 128 | FGFR3 | 0.26291153 |
| 129 | PRKCB | 0.24110796 |
| 130 | DAPK1 | 0.18920047 |
| 131 | CAMK2D | 0.18871856 |
| 132 | RAF1 | 0.18785137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.80405083 |
| 2 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 3.46205297 |
| 3 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 3.36536952 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.62343542 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.13749368 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.09163904 |
| 7 | * Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 2.08556594 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.02341597 |
| 9 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.01320022 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 1.88424387 |
| 11 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.88035758 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 1.84426998 |
| 13 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84260237 |
| 14 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.81112680 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.81047376 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.75410412 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.74804695 |
| 18 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.71734468 |
| 19 | GABAergic synapse_Homo sapiens_hsa04727 | 1.70143701 |
| 20 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.68701426 |
| 21 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.60859264 |
| 22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.57576073 |
| 23 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.54201710 |
| 24 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.51872116 |
| 25 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.46452071 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.32374083 |
| 27 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.32123705 |
| 28 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.30416144 |
| 29 | Morphine addiction_Homo sapiens_hsa05032 | 1.30248275 |
| 30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.29424292 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.26207673 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.24170822 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22957340 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.21886701 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.20489787 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.19133988 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18223520 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.17698912 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.17067969 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.16489100 |
| 41 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.13890274 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.08366935 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06799187 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.03402460 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.01651100 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01447865 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.00300727 |
| 48 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.98118613 |
| 49 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96587236 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.96329720 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94465842 |
| 52 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.93280463 |
| 53 | Thyroid cancer_Homo sapiens_hsa05216 | 0.90701914 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 0.87376123 |
| 55 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86860173 |
| 56 | Melanogenesis_Homo sapiens_hsa04916 | 0.84964353 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83339584 |
| 58 | Bile secretion_Homo sapiens_hsa04976 | 0.81398372 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80732190 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.78930823 |
| 61 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77185507 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76180029 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75766455 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74730192 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73997252 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.73400849 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.72589154 |
| 68 | Axon guidance_Homo sapiens_hsa04360 | 0.72366069 |
| 69 | Melanoma_Homo sapiens_hsa05218 | 0.71328233 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.70264814 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.70114910 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69646634 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68059009 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67444184 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67284471 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65692119 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65020449 |
| 78 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.64669069 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64620309 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63585820 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62830495 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62370018 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61968281 |
| 84 | Phototransduction_Homo sapiens_hsa04744 | 0.60327100 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58678931 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58512584 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57790068 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57242642 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.57068421 |
| 90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.56679097 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55329642 |
| 92 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55108871 |
| 93 | Alcoholism_Homo sapiens_hsa05034 | 0.50694758 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50427793 |
| 95 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50357597 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46198664 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44343252 |
| 98 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42552630 |
| 99 | Phagosome_Homo sapiens_hsa04145 | 0.39551417 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36977399 |
| 101 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.36849899 |
| 102 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36467944 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35767974 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35192203 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34699472 |
| 106 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.34293936 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34247445 |
| 108 | Tight junction_Homo sapiens_hsa04530 | 0.33426293 |
| 109 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.31181278 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29226030 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25918331 |
| 112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25641314 |
| 113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.25133853 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22122908 |
| 115 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.21971224 |
| 116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.18767850 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.18173281 |
| 118 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.17937787 |

